Ardent Health (NYSE:ARDT) Lowered to “Strong Sell” Rating by Zacks Research

Posted by Geri Gentry on Aug 8th, 2026

Zacks Research lowered shares of Ardent Health (NYSE:ARDT – Free Report) from a hold rating to a strong sell rating in a report released on Thursday,Zacks.com reports.

Several other research analysts have also commented on ARDT. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $13.00 price objective on shares of Ardent Health in a research note on Thursday. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. Guggenheim lifted their price target on shares of Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Thursday. Royal Bank Of Canada cut their price target on shares of Ardent Health from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Thursday, July 9th. Finally, Wall Street Zen lowered shares of Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $12.95.

Check Out Our Latest Stock Analysis on Ardent Health

Ardent Health Price Performance

NYSE:ARDT opened at $11.57 on Thursday. The firm has a market capitalization of $1.66 billion, a price-to-earnings ratio of 21.04, a PEG ratio of 3.33 and a beta of 0.70. Ardent Health has a 1 year low of $7.71 and a 1 year high of $15.48. The business has a 50 day simple moving average of $9.98 and a 200-day simple moving average of $9.50. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00.

Ardent Health (NYSE:ARDT – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.06). Ardent Health had a net margin of 1.22% and a return on equity of 10.45%. The company had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Equities analysts forecast that Ardent Health will post 0.95 EPS for the current year.

Insiders Place Their Bets

In other Ardent Health news, CFO Alfred Lumsdaine bought 10,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the transaction, the chief financial officer owned 329,183 shares in the company, valued at $2,900,102.23. This trade represents a 3.13% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.90% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ARDT. Caitong International Asset Management Co. Ltd grew its stake in Ardent Health by 1,177.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after acquiring an additional 2,638 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in shares of Ardent Health during the third quarter valued at approximately $61,000. New York State Common Retirement Fund raised its stake in shares of Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after acquiring an additional 3,400 shares in the last quarter. Monetary Solutions Ltd purchased a new stake in shares of Ardent Health in the fourth quarter valued at approximately $79,000. Finally, Abel Hall LLC bought a new position in Ardent Health in the first quarter worth approximately $87,000.

About Ardent Health

(Get Free Report)

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.